Status:
TERMINATED
A Pilot Study of Prostate Cancer-specific Anxiety in Active Surveillance
Lead Sponsor:
NYU Langone Health
Conditions:
Prostate Cancer
Eligibility:
MALE
40+ years
Phase:
NA
Brief Summary
This study is a clinical trial to determine whether a 12-week group therapy intervention for patients undergoing Active Surveillance for Prostate Cancer can relieve disease-related anxiety and improve...
Eligibility Criteria
Inclusion
- Age of 40
- Primary diagnosis of Prostate Cancer
- Initial MAX-PC score of ≥16.
- Sign a consent form allowing related information to be included in this research.
Exclusion
- Prostate cancer is not their primary diagnosis.
- Have pre-existing diagnosed psychiatric conditions, are currently taking psychotropic medications (e.g., antidepressants, anxiolytics, mood stabilizers.)
- Have been diagnosed with cancer other than prostate cancer (and non-melanoma skin cancer)
- Evidence of active substance abuse.
- Participants in the treatment group who are absent from more than 3 therapy sessions will be excluded.
Key Trial Info
Start Date :
April 19 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 28 2018
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT03227744
Start Date
April 19 2017
End Date
December 28 2018
Last Update
February 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Winthrop Hospital
Mineola, New York, United States, 11501